Full text is available at the source.
Abstract
Few data inform implementation of emerging state-regulated psilocybin programs.
- Current knowledge about psilocybin programs is limited.
- Existing data may not adequately support the rollout of these programs.
- More comprehensive research could be necessary to guide effective implementation.
- Potential challenges in integrating psilocybin into healthcare systems are not well understood.
Simplified